Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology

Free Medical Books

  Chronic Heart Failure

  Free Subscription


Articles published in J Cardiovasc Pharmacol

Retrieve available abstracts of 20 articles:
HTML format
Text format



Single Articles


    October 2011
  1. MACHIDA M , Takechi S, Fujimoto T, Kakinoki S, et al
    Carvedilol improves uptake-1 in patients with systolic congestive heart failure.
    J Cardiovasc Pharmacol. 2011.
    PubMed     Text format     Related articles    Abstract available



  2. NISSEN JD , Thomsen MB, Bentzen BH, Diness JG, et al
    Attenuated Ventricular beta-Adrenergic Response and Reduced Repolarisation Reserve in a Rabbit Model of Chronic Heart Failure.
    J Cardiovasc Pharmacol. 2011.
    PubMed     Text format     Related articles    Abstract available



    August 2011
  3. OGAWA K , Hirooka Y, Kishi T, Sunagawa K, et al
    Brain AT1 Receptor Activates the Sympathetic Nervous System through Toll-like Receptor 4 in Mice with Heart Failure.
    J Cardiovasc Pharmacol. 2011.
    PubMed     Text format     Related articles    Abstract available



  4. DEL RY S , Cabiati M, Martino A, Simioniuc A, et al
    Adenosine receptor mRNA expression in normal and failing minipig hearts.
    J Cardiovasc Pharmacol. 2011;58:149-56.
    PubMed     Text format     Related articles    Abstract available



    June 2011
  5. CHAN V , Fenning A, Phd AH, Phd LB, et al
    CHRONIC beta-ADRENOCEPTOR ANTAGONIST TREATMENT CONTROLS CARDIOVASCULAR REMODELING IN HEART FAILURE IN THE AGEING SPONTANEOUSLY HYPERTENSIVE RAT: Metoprolol and cardiovascular changes in SHR.
    J Cardiovasc Pharmacol. 2011.
    PubMed     Text format     Related articles    Abstract available



  6. BARTHA E , Solti I, Szabo A, Olah G, et al
    Regulation of kinase cascade activation and heat shock protein expression by poly(ADP-ribose) polymerase inhibition in doxorubicin-induced heart failure.
    J Cardiovasc Pharmacol. 2011.
    PubMed     Text format     Related articles    Abstract available



  7. FEDELE F , D'ambrosi A, Bruno N, Caira C, et al
    COST-EFFECTIVENESS OF LEVOSIMENDAN IN PATIENTS WITH ACUTE HEART FAILURE.
    J Cardiovasc Pharmacol. 2011.
    PubMed     Text format     Related articles    Abstract available



  8. CAIMMI PP , Kapetanakis EI, Beggino C, Molinari C, et al
    Management of Acute Cardiac Failure by Intracoronary Administration of Levosimendan.
    J Cardiovasc Pharmacol. 2011.
    PubMed     Text format     Related articles    Abstract available



    February 2011
  9. HOFFMAN TM
    Newer Inotropes in Pediatric Heart Failure.
    J Cardiovasc Pharmacol. 2011.
    PubMed     Text format     Related articles    Abstract available



    January 2011
  10. CHAN V , Fenning A, Levick SP, Loch D, et al
    CARDIOVASCULAR CHANGES DURING MATURATION AND AGEING IN MALE AND FEMALE SPONTANEOUSLY HYPERTENSIVE RATS.
    J Cardiovasc Pharmacol. 2011.
    PubMed     Text format     Related articles    Abstract available



    November 2010
  11. WANG Z
    The role of microRNA in cardiac excitability.
    J Cardiovasc Pharmacol. 2010;56:460-70.
    PubMed     Text format     Related articles    Abstract available



    October 2010
  12. TANG Y , Long CL, Wang RH, Cui W, et al
    Activation of SUR2B/Kir6.1 subtype of adenosine triphosphate-sensitive potassium channel improves pressure overload-induced cardiac remodeling via protecting endothelial function.
    J Cardiovasc Pharmacol. 2010;56:345-53.
    PubMed     Text format     Related articles    Abstract available



    September 2010
  13. XU K , George I, Klotz S, Hay I, et al
    Erythropoietin Derivate Improves Left Ventricular Systolic Performance and Attenuates Left Ventricular Remodeling in Rats with Myocardial Infarct-Induced Heart Failure.
    J Cardiovasc Pharmacol. 2010.
    PubMed     Text format     Related articles    Abstract available



    August 2010
  14. DAVID PORT J , Sucharov C
    Role of microRNAs in Cardiovascular Disease: Therapeutic Challenges and Potentials.
    J Cardiovasc Pharmacol. 2010.
    PubMed     Text format     Related articles    Abstract available



    June 2010
  15. KAMALOV G , Bhattacharya SK, Weber KT
    Congestive Heart Failure: Where Homeostasis Begets Dyshomeostasis.
    J Cardiovasc Pharmacol. 2010.
    PubMed     Text format     Related articles    Abstract available



  16. MISHRA S , Ling H, Grimm M, Zhang T, et al
    Cardiac Hypertrophy and Heart Failure Development Through Gq and CaM Kinase II Signaling.
    J Cardiovasc Pharmacol. 2010.
    PubMed     Text format     Related articles    Abstract available



  17. VERRIER RL , Nieminen T
    T-wave alternans as a therapeutic marker for antiarrhythmic agents.
    J Cardiovasc Pharmacol. 2010;55:544-54.
    PubMed     Text format     Related articles    Abstract available



  18. BAUER A , Zurn CS, Schmidt G
    Heart rate turbulence to guide treatment for prevention of sudden death.
    J Cardiovasc Pharmacol. 2010;55:531-8.
    PubMed     Text format     Related articles    Abstract available



  19. SURYAKUMAR G , Kasiganesan H, Balasubramanian S, Kuppuswamy D, et al
    Lack of beta3 integrin signaling contributes to calpain-mediated myocardial cell loss in pressure-overloaded myocardium.
    J Cardiovasc Pharmacol. 2010;55:567-73.
    PubMed     Text format     Related articles    Abstract available



    January 2010
  20. WANG Y , Moreira Mda C, Heringer-Walther S, Schultheiss HP, et al
    Amino-terminal fragment of C-type natriuretic peptide precursor and C-type natriuretic peptide do not correlate in patients with Chagas disease: role for neutral endopeptidase.
    J Cardiovasc Pharmacol. 2010;55:62-6.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: